/image%2F3334645%2F20201111%2Fob_fd07bb_sans-titre-1.jpg)
/image%2F3334645%2F20260815%2Fob_bc620d_776497617-2038408443455296-23321386311.jpg "What Makes Witch Hazel Effective? Science, Mechanisms, and Clinical Evidence")
/image%2F3334645%2F20260815%2Fob_0b61ff_1648b369-8789-4bda-ba8e-e0f14509b143.jpg "Witch Hazel and Its Health Benefits: What the Research Shows")
/image%2F3334645%2F20260813%2Fob_b43f9c_769309559-2140073886540951-57767507467.net%26_nc_cat%3D103%26_nc_ohc%3D4QRjV1Bt6mMQ7kNvwEXX8Hm%26sdl%3D0%26ccb%3D14-4%26oh%3D00_AQEewd55H0n7-7rqoPxlPHipVunD0UlbK_kX7bWw4GptTQ%26oe%3D6A840C87%26_nc_sid%3Da21977 "Theoretical Foundations of Cold Laser Water Imprinting")
/image%2F3334645%2F20260813%2Fob_c7a592_bdff188c-2305-4a08-bbd1-19ddd0b42cfe.jpg "Cold Laser-Based Water Imprinting: A Review of Exposure Duration and Proposed Mechanisms")
/image%2F3334645%2F20260812%2Fob_1114bb_aug-12-2026-03-02-57-pm.png "From Resonant Frequencies to Biological Effects: Experimental Extensions of the Resonant Recognition Model")
/image%2F3334645%2F20260810%2Fob_8634c6_oig1.yWdw_LTFGSh7hPhQqazw%3Fw%3D1024%26h%3D1024%26qlt%3D70%26p%3D0%26r%3D0%26o%3D4%26pid%3DImgGn "The Resonant Recognition Model: Searching for Hidden Frequencies in DNA and Proteins")
/image%2F3334645%2F20260806%2Fob_33a5c3_imefefzage-1-c.jpg "Soquelitinib: A Potential New Treatment for Inflammatory Diseases")
/image%2F3334645%2F20260805%2Fob_afeba9_766221654-1377354427854223-55085509030.net%26_nc_cat%3D107%26_nc_ohc%3Df91CASdi6pcQ7kNvwGY-dZI%26sdl%3D0%26ccb%3D14-4%26oh%3D00_AQGGIMtSjoq8bH-AjqOyCYJO-jCK3Ds3w2WAlVSahh6y0Q%26oe%3D6A796F59%26_nc_sid%3Da21977 "Deeper Molecular Signatures: Fluorescence, NMR, Terahertz, and Circularly Polarized Emission")
/image%2F3334645%2F20260804%2Fob_9e339a_763992749-1764300548032994-46344489975.jpg "Spectroscopic Fingerprinting of Molecules: Theory, Measurement, and Real-World Applications")
/image%2F3334645%2F20260802%2Fob_b5c418_f3795fe1-14d0-4417-bd7c-d91c613666b2.jpg "Alpha-Tocopherol and Skin Health: The Science Behind Vitamin E")
Purinergic Miscommunication in Pain, Cancer, and Neurodegeneration
/image%2F3334645%2F20251221%2Fob_cd315c_unnamed.jpg)
When the precise language of purinergic signalling breaks down—when the volume of the conversation is turned too high, turned too low, or the messages become garbled—it can contribute to the development or progression of many diseases. Understanding this helps explain why researchers are so focused on developing drugs that can correct this faulty cellular dialogue.
Think back to the city analogy. In a healthy body, the "ATP alert" signal is used for brief, local emergencies—like a construction crew putting up a temporary "Caution" sign to repair a sidewalk. In certain diseases, however, this alert signal gets stuck in the "on" position. This is a major factor in chronic pain disorders, like neuropathic pain. Damaged or over-excited nerves release too much ATP, which constantly screams "Pain!" to neighbouring nerves, even long after the original injury has healed. Similarly, in diseases of chronic inflammation—such as rheumatoid arthritis, inflammatory bowel disease, or atherosclerosis—immune cells release excessive ATP at the site, perpetuating a cycle of inflammation, tissue damage, and more ATP release, much like a false alarm that triggers an endless, damaging emergency response.
Conversely, problems can arise when the calming "adenosine" part of the conversation is too weak or is ignored. In epilepsy, for instance, the brain's neurons become hyperactive and fire in an uncontrolled storm. Normally, adenosine released during brain activity acts as a natural brake to calm this excitement. If this purinergic braking system is insufficient, seizures can propagate. The same principle applies to certain anxiety disorders, where a deficit in calming signals may contribute to a state of persistent neuronal excitability.
Perhaps one of the most profound areas of dysfunction is in neurodegenerative diseases. In conditions like Alzheimer's and Parkinson's disease, the slow, progressive damage to brain cells causes them to leak ATP and other signals. This initially triggers a protective inflammatory response from the brain's immune cells (microglia). But as the disease continues, this purinergic "distress call" is never resolved. The sustained activation of microglia via purinergic receptors pushes them into a harmful, chronic state where they actually begin to damage the very neurons they are supposed to protect, accelerating the disease process.
Finally, cancer cells are notorious hackers of biological systems, and purinergic signalling is no exception. Tumours often create a microenvironment rich in ATP and adenosine. Here, they use the signals to their advantage: the ATP can help fuel dangerous growth and invasion, while the adenosine acts as a powerful immunosuppressant, putting the body's immune cells (like T-cells) to sleep right at the tumour's doorstep. This clever manipulation of the purinergic language allows the cancer to both grow aggressively and hide from the immune system's defences.
Therefore, by developing drugs that can mute the excessive "ATP alarm," boost the calming "adenosine signal," or block the receptors that hear these corrupted messages, scientists aim to create new treatments for pain, inflammation, neurodegeneration, and cancer. They are essentially designing molecular tools to correct the conversation and restore the delicate balance of health.
(Source : DeepSeek)
